Ann: Results of Phase 2 Clinical Trial, page-21

Ladies and Gentlemen, please take this result as actually the absolute norm in the biotech sector. If you invest in biotechs u need to have the attitude that it will most likely fail as the failure rate to get a drug to commercialisation is greater than 95% (even though you might think the company's chemical compound looks like a ball tearer in the early stages). All drugs usually go through the same steps and trials to get to commercialisation which test for safety and whether the drug meets its endpoints (another way saying whether the drug meets certain performance hurdles that can be measured taking out subjectivity) The biotech sector is the closest form of gambling on the stockmarket. You really need to have an understanding in the medical/chemical type subjects to lessen your risks. Apologies to all shareholders that have made a loss but please use this as a big lesson.